Dabigatran etexilate Completed Phase 3 Trials for Thromboembolism / Arthroplasty, Replacement, Hip Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00168818Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery